Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A45620 | 23620309 | Angiology | Response to the letter "nonalcoholic fatty liver disease may be associated with coronary artery disease complexity". | 2013 | Details |
| A45621 | 23610585 | Hepat Mon | Probiotic as a novel treatment strategy against liver disease. | 2013 | Details |
| A45622 | 23602251 | Nutr Res | Gly482Ser mutation impairs the effects of peroxisome proliferator-activated receptor γ coactivator-1α on decreasing fat deposition and stimulating phosphoenolpyruvate carboxykinase expression in hepatocytes. | 2013 | Details |
| A45623 | 23599638 | World J Gastroenterol | Alcohol consumption and fatty liver disease. | 2013 | Details |
| A45624 | 23591557 | Curr Opin Cardiol | Epicardial fat and vascular risk: a narrative review. | 2013 | Details |
| A45625 | 23582593 | Curr Probl Pediatr Adolesc Health Care | Metabolic syndrome in pediatrics: old concepts revised, new concepts discussed. | 2013 | Details |
| A45626 | 23578845 | Med Clin (Barc) | [Fatty liver and metabolic syndrome]. | 2013 | Details |
| A45627 | 23568051 | J Pediatr Gastroenterol Nutr | Liver toxicity of anabolic androgenic steroid use in an adolescent with nonalcoholic fatty liver disease. | 2014 | Details |
| A45628 | 23566931 | Clin Chim Acta | Upper limit of normal for alanine aminotransferase: quo vadis? | 2013 | Details |
| A45629 | 23564302 | Clin Pediatr (Phila) | Hepatic cirrhosis secondary to nonalcoholic fatty liver disease in a 12-year-old girl with morbid obesity. | 2013 | Details |
| A45630 | 23564020 | Angiology | Nonalcoholic Fatty liver disease may be associated with coronary artery disease complexity. | 2013 | Details |
| A45631 | 26366024 | Appl Radiol | MR Elastography of Liver Disease: State of the Art. | 2013 | Details |
| A45632 | 23536474 | Hepatology | Regulation of cholesterol and bile acid homeostasis by the cholesterol 7α-hydroxylase/steroid response element-binding protein 2/microRNA-33a axis in mice. | 2013 | Details |
| A45633 | 23520198 | Obesity (Silver Spring) | Why do we need drugs to treat the patient with obesity? | 2013 | Details |
| A45634 | 23512597 | Obesity (Silver Spring) | Modest fructose beverage intake causes liver injury and fat accumulation in marginal copper deficient rats. | 2013 | Details |
| A45635 | 23510587 | Lipids Health Dis | Micronutrients-fortified rapeseed oil improves hepatic lipid accumulation and oxidative stress in rats fed a high-fat diet. | 2013 | Details |
| A45636 | 23508978 | Dig Dis Sci | Dyslipidemia and non-alcoholic fatty liver disease. | 2013 | Details |
| A45637 | 23508615 | Angiology | Nonalcoholic fatty liver disease and severity of cardiovascular disease manifestations. | 2013 | Details |
| A45638 | 23504746 | Hepatology | Furthering the understanding of maternal obesity in nonalcoholic fatty liver disease. | 2013 | Details |
| A45639 | 23503327 | Endocr J | Comments on "High serum vitamin D levels reduce the risk for nonalcoholic fatty liver disease in healthy men independent of metabolic syndrome". | 2013 | Details |
| A45640 | 23495130 | Liver Transpl | High prevalence of vitamin A deficiency and vitamin D deficiency in patients evaluated for liver transplantation. | 2013 | Details |
| A45641 | 23493541 | Adv Nutr | Challenging the fructose hypothesis: new perspectives on fructose consumption and metabolism. | 2013 | Details |
| A45642 | 23493538 | Adv Nutr | Energy and fructose from beverages sweetened with sugar or high-fructose corn syrup pose a health risk for some people. | 2013 | Details |
| A45643 | 23486979 | J Nutr | Fatty liver accompanies an increase in lactobacillus species in the hind gut of C57BL/6 mice fed a high-fat diet. | 2013 | Details |
| A45644 | 23484104 | Biomed Res Int | Progesterone and related compounds in hepatocellular carcinoma: basic and clinical aspects. | 2013 | Details |
| A45645 | 23482364 | Georgian Med News | [Role of proapoptotic p-53 factor in pathogenesis of nonalcoholic hepatosteatosis]. | 2013 | Details |
| A45646 | 23475416 | Endocr Rev | Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals. | 2013 | Details |
| A45647 | 23474422 | Gut | Yin Yang 1 and farnesoid X receptor: a balancing act in non-alcoholic fatty liver disease? | 2013 | Details |
| A45648 | 23471889 | Diabetes Metab Res Rev | Hepatic manifestations of metabolic syndrome. | 2013 | Details |
| A45649 | 23467323 | Am J Physiol Regul Integr Comp Physiol | Hepatic steatosis development with four weeks of physical inactivity in previously active, hyperphagic OLETF rats. | 2013 | Details |
| A45650 | 23448493 | Curr Pharm Des | Endothelial dysfunction in morbid obesity. | 2013 | Details |
| A45651 | 23448486 | Curr Pharm Des | Role of adiponectin in the metabolic syndrome: current perspectives on its modulation as a treatment strategy. | 2013 | Details |
| A45652 | 23447428 | Hepatology | Adiponectin, bile acids, and burnt-out nonalcoholic steatohepatitis: new light on an old paradox. | 2013 | Details |
| A45653 | 26201617 | Hepatol Int | Angiogenesis: a phenomenon which aggravates chronic liver disease progression. | 2012 | Details |
| A45654 | 23440555 | J Gastroenterol | Insulin-related biomarkers and their relationship with hepatic fibrosis risk in patients with psoriasis, metabolic syndrome and non-alcoholic fatty liver disease. | 2013 | Details |
| A45655 | 23438451 | Toxicol Appl Pharmacol | Proinflammatory adipokine leptin mediates disinfection byproduct bromodichloromethane-induced early steatohepatitic injury in obesity. | 2013 | Details |
| A45656 | 23424925 | Rev Prat | [Lesions in nanolcoholic fatty liver disease]. | 2012 | Details |
| A45657 | 23423574 | Diabetes | Targeting pyruvate carboxylase reduces gluconeogenesis and adiposity and improves insulin resistance. | 2013 | Details |
| A45658 | 23409094 | PLoS One | Dietary sphingomyelin lowers hepatic lipid levels and inhibits intestinal cholesterol absorption in high-fat-fed mice. | 2013 | Details |
| A45659 | 23406410 | Aliment Pharmacol Ther | Letter: FibroTest for staging fibrosis in non-alcoholic fatty liver disease - authors' reply. | 2013 | Details |
| A45660 | 23406408 | Aliment Pharmacol Ther | Letter: FibroTest for staging fibrosis in non-alcoholic fatty liver disease. | 2013 | Details |
| A45661 | 23405399 | Zhonghua Gan Zang Bing Za Zhi | [Serum dipeptidyl peptidase N levels in obese children with nonalcoholic fatty liver disease]. | 2012 | Details |
| A45662 | 23401290 | Hepatology | Liver fatty acid binding protein (L-Fabp) modulates murine stellate cell activation and diet-induced nonalcoholic fatty liver disease. | 2013 | Details |
| A45663 | 23394098 | Curr Pharm Des | Update on treatment strategies in patients with non-alcoholic fatty liver disease. | 2013 | Details |
| A45664 | 23379005 | Zhonghua Gan Zang Bing Za Zhi | [Attention to the progress of the genetic risk factors for non-alcoholic fatty liver disease (NAFLD]. | 2012 | Details |
| A45665 | 23376365 | J Hepatol | Focus. | 2013 | Details |
| A45666 | 23374710 | Vitam Horm | Hormonal regulation of lipogenesis. | 2013 | Details |
| A45667 | 23369167 | Aliment Pharmacol Ther | Letter: Is visceral adiposity index a predictor of liver histology in patients with non-alcoholic fatty liver disease? | 2013 | Details |
| A45668 | 23361473 | J Gastroenterol | Reply to the letter by Lai et al. regarding "body mass index is the most useful predictive factor for the onset of nonalcoholic fatty liver disease: a community-based retrospective longitudinal study". | 2013 | Details |
| A45669 | 23352427 | Can J Cardiol | Reply to Mirrakhimov and Mirrakhimov--nonalcoholic fatty liver disease and cardiovascular risk in obese children and adolescents. | 2013 | Details |
| A45670 | 23351623 | J Acad Nutr Diet | Dietary intervention in non-alcoholic fatty liver disease. | 2013 | Details |
| A45671 | 23333451 | J Hepatol | Bariatric surgery for curing NASH in the morbidly obese? | 2013 | Details |
| A45672 | 23330546 | Drug Metab Rev | Nuclear receptors in bile acid metabolism. | 2013 | Details |
| A45673 | 23325165 | J Gastroenterol | Body mass index and nonalcoholic fatty liver disease. | 2013 | Details |
| A45674 | 23323250 | Clin Mol Hepatol | Elevated serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease. | 2012 | Details |
| A45675 | 23322813 | Environ Health Perspect | Transgenerational inheritance of increased fat depot size, stem cell reprogramming, and hepatic steatosis elicited by prenatal exposure to the obesogen tributyltin in mice. | 2013 | Details |
| A45676 | 23320276 | Zhonghua Gan Zang Bing Za Zhi | [Roles of kupffer cells activation in pathogenesis and progression of non-alcoholic fatty liver disease]. | 2012 | Details |
| A45677 | 23316217 | PPAR Res | PPAR Could Contribute to the Pathogenesis of Hepatocellular Carcinoma. | 2012 | Details |
| A45678 | 23305377 | Curr Vasc Pharmacol | Editorial: Exploring Lipid-related Treatment Options for the Treatment of NASH. | 2014 | Details |
| A45679 | 23304111 | PPAR Res | Misregulation of PPAR Functioning and Its Pathogenic Consequences Associated with Nonalcoholic Fatty Liver Disease in Human Obesity. | 2012 | Details |
| A45680 | 23299663 | Hepatology | 3 Tesla diffusion-weighted MRI for assessing liver fibrosis in nonalcoholic fatty liver disease. | 2013 | Details |
| A45681 | 23298629 | J Hepatol | Drug-induced liver injury in obesity. | 2013 | Details |
| A45682 | 23297154 | Hepatology | Reply: To PMID 22488764. | 2013 | Details |
| A45683 | 23296246 | Nat Rev Gastroenterol Hepatol | Liver fibrosis in 2012: Convergent pathways that cause hepatic fibrosis in NASH. | 2013 | Details |
| A45684 | 23295629 | Food Chem Toxicol | Protective effects of matrine against progression of high-fructose diet-induced steatohepatitis by enhancing antioxidant and anti-inflammatory defences involving Nrf2 translocation. | 2013 | Details |
| A45685 | 23293210 | Ann Hepatol | Probiotics: a possible role in treatment of adult and pediatric non alcoholic fatty liver disease. | 2013 | Details |
| A45686 | 23292069 | FASEB J | Genetic signatures in choline and 1-carbon metabolism are associated with the severity of hepatic steatosis. | 2013 | Details |
| A45687 | 23287313 | Food Chem Toxicol | Effect of pigeon pea (Cajanus cajan L.) on high-fat diet-induced hypercholesterolemia in hamsters. | 2012 | Details |
| A45688 | 27335825 | ISRN Hepatol | Mild Hypertransaminasemia in Primary Care. | 2013 | Details |
| A45689 | 23269715 | J Ultrasound Med | Evaluation of carotid artery stiffness in obese children using ultrasound radiofrequency data technology. | 2013 | Details |
| A45690 | 23265092 | Can J Cardiol | Nonalcoholic fatty liver disease and cardiovascular risk: is there a place for obstructive sleep apnea? | 2012 | Details |
| A45691 | 23261413 | Clin Gastroenterol Hepatol | Biopsy no more; changing the screening and diagnostic algorithm for hepatitis C. | 2012 | Details |
| A45692 | 23260099 | J Pediatr | Intrahepatic fat is increased in the neonatal offspring of obese women with gestational diabetes. | 2012 | Details |
| A45693 | 23259217 | Lakartidningen | [Non-alcoholic fatty liver disease can cause permanent liver damage]. | 2013 | Details |
| A45694 | 23252777 | Aliment Pharmacol Ther | Commentary: assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers--authors' reply. | 2013 | Details |
| A45695 | 23252776 | Aliment Pharmacol Ther | Commentary: assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers. | 2013 | Details |
| A45696 | 23247068 | J Hepatol | Focus. | 2012 | Details |
| A45697 | 23222203 | Pol Arch Med Wewn | Metformin superior to low‑fat diet for the treatment of patients with nonalcoholic fatty liver disease and/or steatohepatitis. | 2012 | Details |
| A45698 | 23236625 | Curr Opin Clin Nutr Metab Care | Bibliography. Micronutrients. Current world literature. | 2012 | Details |
| A45699 | 23230595 | Zhonghua Gan Zang Bing Za Zhi | [Brief introduction of guidelines for liver transplantation for patients with non-alcoholic steatohepatitis by British Transplant Society]. | 2012 | Details |
| A45700 | 23230594 | Zhonghua Gan Zang Bing Za Zhi | [Brief introduction of American practice guideline for the diagnosis and management of non-alcoholic fatty liver disease]. | 2012 | Details |
| A45701 | 23225262 | Hepatology | Flipping the switch. | 2013 | Details |
| A45702 | 23213025 | Hepatology | Hepatoprotective and antiviral functions of silymarin components in hepatitis C virus infection. | 2013 | Details |
| A45703 | 23200777 | Toxicol Appl Pharmacol | Liver proteomics in progressive alcoholic steatosis. | 2012 | Details |
| A45704 | 23185654 | J Cardiovasc Ultrasound | Non-Alcoholic Fatty Liver Disease, a Marker of Subclinical Atherosclerosis Applicable Only to Metabolic Syndrome?: Time to Organize the Connection between Metabolism and Atherosclerosis. | 2012 | Details |
| A45705 | 23177179 | Nutr Metab Cardiovasc Dis | Probiotics in the treatment of non alcoholic fatty liver disease: further evidence in obese children. | 2012 | Details |
| A45706 | 23175343 | Postepy Hig Med Dosw (Online) | [Role of sphingolipids in digestive system]. | 2012 | Details |
| A45707 | 23175050 | Hepatology | Role of patatin-like phospholipase domain-containing 3 on lipid-induced hepatic steatosis and insulin resistance in rats. | 2013 | Details |
| A45708 | 23170042 | J Clin Biochem Nutr | Analysis of vanin-1 upregulation and lipid accumulation in hepatocytes in response to a high-fat diet and free fatty acids. | 2012 | Details |
| A45709 | 23161873 | Endocrinology | The role of the carbohydrate response element-binding protein in male fructose-fed rats. | 2012 | Details |
| A45710 | 23156704 | J Zoo Wildl Med | Hemochromatosis and fatty liver disease: building evidence for insulin resistance in bottlenose dolphins (Tursiops truncatus). | 2012 | Details |
| A45711 | 23156452 | Nihon Rinsho | [NAFLD, NASH]. | 2012 | Details |
| A45712 | 23156387 | Nihon Rinsho | [Glucose intolerance in chronic liver disease]. | 2012 | Details |
| A45713 | 23144998 | PLoS One | Type 2 diabetes associated changes in the plasma non-esterified fatty acids, oxylipins and endocannabinoids. | 2012 | Details |
| A45714 | 23129535 | Sleep Breath | Obstructive sleep apnea and dyslipidemia: pathophysiological mechanisms. | 2012 | Details |
| A45715 | 23127162 | Metab Syndr Relat Disord | The evolving scenario of copper and fatty liver. | 2012 | Details |
| A45716 | 23126101 | Nihon Rinsho | [Extraintestinal complications of inflammatory bowel disease]. | 2012 | Details |
| A45717 | 23115010 | Hepatology | Cholesterol and nonalcoholic fatty liver disease: renewed focus on an old villain. | 2012 | Details |
| A45718 | 23112961 | Front Cell Infect Microbiol | Causative role of gut microbiota in non-alcoholic fatty liver disease pathogenesis. | 2012 | Details |
| A45719 | 23111985 | Hepatology | Circulating MicroRNA-122 signature in nonalcoholic fatty liver disease and cardiovascular disease: a new endocrine system in metabolic syndrome. | 2013 | Details |